{
  "retracted": false,
  "timestamp": 1160438400000,
  "updates": [
    {
      "timestamp": 1495870729464,
      "identifier": {
        "doi": "10.1212/01.wnl.0000249589.31758.5a"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1212/01.wnl.0000234967.76960.3c"
  },
  "journal": "Neurology",
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Correspondence about Brief Communication \"Is protracted low-dose temozolomide feasible in glioma patients?\""
}
